Asia Pacific Antiplatelet Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, and Injectable), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023

Description

List of Tables

The Asia Pacific Antiplatelet Market would witness market growth of 5.5% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 111.9 million Units, showcasing a growth of 4.0% (2019-2022).

The prevalence of antithrombotic/anticoagulant medications, the aging population, an upsurge in thrombotic events, and recent pharmaceutical advancements are some of the main factors driving the market. Antithrombotic agents are substances that prevent blood clotting from forming. Antithrombotic could be used therapeutically for prevention (primary prevention, secondary prevention) or treatment of a hazardous blood clot (acute thrombus).

The demand for antiplatelet pharmaceuticals is not limited to developed nations but is also witnessed in developing countries, which is anticipated to propel market growth. Additionally, the market for antiplatelets is expanding due to increased government initiatives for cardiovascular disorders, including stroke. Under the National Programme for the Prevention and Control of Cancer, Cardiovascular Diseases, Diabetes, and Stroke (NPCDCS), the Department of Health & Family Welfare, Government of India, provides technical and financial support to the States/UTs. Campaigns for awareness, screening programs, and subsidized access to drugs are frequently included in these activities.

As per International Trade Administration, in 2018, China's healthcare sector exhibited continuous, robust expansion and dynamic regulatory shifts. The sector for medical devices in China reached approximately USD 70 billion. The demand for medical devices has maintained double-digit growth for over a decade, making it one of China's fastest-growing markets. Over 70% of this expansion had attributable to hospital procurement. In recent years, the Asia Pacific region has seen a considerable rise in research and development (R&D) activities related to antiplatelet therapies and cardiovascular medicine. Hence, with the expanding disease burden and healthcare sector, the market will grow throughout the forecast period.

The China market dominated the Asia Pacific Antiplatelet Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $347.9 Million by 2030. The Japan market is registering a CAGR of 4.8% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.1% during (2023 - 2030).

Based on Route of Administration, the market is segmented into Oral, and Injectable. Based on Drug Class, the market is segmented into Adenosine diphosphate (ADP) Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Others. Based on Distribution Channel, the market is segmented into Drug store & Retail Pharmacies, Hospital Pharmacies, and Online Providers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cipla Limited, Glenmark Pharmaceuticals Limited, Bayer AG, AstraZeneca PLC, Daiichi Sankyo Company, Limited, Eli Lilly And Company, Otsuka Pharmaceutical Co., Ltd., Sanofi S.A. , Lupin Limited and Chiesi Farmaceutici S.p.A.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration (Volume, million Units, USD Million, 2019-2030)

Oral
Injectable

By Drug Class (Volume, million Units, USD Million, 2019-2030)

Adenosine diphosphate (ADP) Receptor Inhibitors
Irreversible Inhibitors Cyclooxygenase
Others

By Distribution Channel (Volume, million Units, USD Million, 2019-2030)

Drug store & Retail Pharmacies
Hospital Pharmacies
Online Providers

By Country (Volume, Million Units, USD Million, 2019-2030)

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Companies Profiled

Cipla Limited
Glenmark Pharmaceuticals Limited
Bayer AG
AstraZeneca PLC
Daiichi Sankyo Company, Limited
Eli Lilly And Company
Otsuka Pharmaceutical Co., Ltd.
Sanofi S.A.
Lupin Limited
Chiesi Farmaceutici S.p.A

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Antiplatelet Market, by Route of Administration
- 1.4.2 Asia Pacific Antiplatelet Market, by Drug Class
- 1.4.3 Asia Pacific Antiplatelet Market, by Distribution Channel
- 1.4.4 Asia Pacific Antiplatelet Market, by Country
1.5 Methodology for the research

Chapter 2. Market At a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Force Analysis

Chapter 4. Asia Pacific Antiplatelet Market by Route of Administration

4.1 Asia Pacific Oral Market by Country
4.2 Asia Pacific Injectable Market by Country

Chapter 5. Asia Pacific Antiplatelet Market by Drug Class

5.1 Asia Pacific Adenosine diphosphate (ADP) Receptor Inhibitors Market by Country
5.2 Asia Pacific Irreversible Inhibitors Cyclooxygenase Market by Country
5.3 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Antiplatelet Market by Distribution Channel

6.1 Asia Pacific Drug store & Retail Pharmacies Market by Country
6.2 Asia Pacific Hospital Pharmacies Market by Country
6.3 Asia Pacific Online Providers Market by Country

Chapter 7. Asia Pacific Antiplatelet Market by Country

7.1 China Antiplatelet Market
- 7.1.1 China Antiplatelet Market by Route of Administration
- 7.1.2 China Antiplatelet Market by Drug Class
- 7.1.3 China Antiplatelet Market by Distribution Channel
7.2 Japan Antiplatelet Market
- 7.2.1 Japan Antiplatelet Market by Route of Administration
- 7.2.2 Japan Antiplatelet Market by Drug Class
- 7.2.3 Japan Antiplatelet Market by Distribution Channel
7.3 India Antiplatelet Market
- 7.3.1 India Antiplatelet Market by Route of Administration
- 7.3.2 India Antiplatelet Market by Drug Class
- 7.3.3 India Antiplatelet Market by Distribution Channel
7.4 South Korea Antiplatelet Market
- 7.4.1 South Korea Antiplatelet Market by Route of Administration
- 7.4.2 South Korea Antiplatelet Market by Drug Class
- 7.4.3 South Korea Antiplatelet Market by Distribution Channel
7.5 Singapore Antiplatelet Market
- 7.5.1 Singapore Antiplatelet Market by Route of Administration
- 7.5.2 Singapore Antiplatelet Market by Drug Class
- 7.5.3 Singapore Antiplatelet Market by Distribution Channel
7.6 Malaysia Antiplatelet Market
- 7.6.1 Malaysia Antiplatelet Market by Route of Administration
- 7.6.2 Malaysia Antiplatelet Market by Drug Class
- 7.6.3 Malaysia Antiplatelet Market by Distribution Channel
7.7 Rest of Asia Pacific Antiplatelet Market
- 7.7.1 Rest of Asia Pacific Antiplatelet Market by Route of Administration
- 7.7.2 Rest of Asia Pacific Antiplatelet Market by Drug Class
- 7.7.3 Rest of Asia Pacific Antiplatelet Market by Distribution Channel

Chapter 8. Company Profiles

8.1 Cipla Limited
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 Glenmark Pharmaceuticals Limited
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 Recent strategies and developments:
  - 8.2.5.1 Approvals:
- 8.2.6 SWOT Analysis
8.3 Bayer AG
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 SWOT Analysis
8.4 AstraZeneca PLC
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 SWOT Analysis
8.5 Daiichi Sankyo Company, Limited
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Product and Services and Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Partnerships, Collaborations, and Agreements:
- 8.5.6 SWOT Analysis
8.6 Eli Lilly And Company
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
8.7 Otsuka Pharmaceutical Co., Ltd.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
8.8 Sanofi S.A.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental and Regional Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 SWOT Analysis
8.9 Lupin Limited
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Regional Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
8.10. Chiesi Farmaceutici S.p.A
- 8.10.1 Company Overview
- 8.10.2 SWOT Analysis

LIST OF TABLES

TABLE 1 Asia Pacific Antiplatelet Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Antiplatelet Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Antiplatelet Market, 2019 - 2022, Million Units
TABLE 4 Asia Pacific Antiplatelet Market, 2023 - 2030, Million Units
TABLE 5 Asia Pacific Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 8 Asia Pacific Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 9 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Oral Market by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Oral (strip of 10) Market by Country, 2019 - 2022, Million Units
TABLE 12 Asia Pacific Oral (strip of 10) Market by Country, 2023 - 2030, Million Units
TABLE 13 Asia Pacific Injectable Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Injectable Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Injectable Market by Country, 2019 - 2022, Million Units
TABLE 16 Asia Pacific Injectable Market by Country, 2023 - 2030, Million Units
TABLE 17 Asia Pacific Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Adenosine diphosphate (ADP) Receptor Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Adenosine diphosphate (ADP) Receptor Inhibitors Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Irreversible Inhibitors Cyclooxygenase Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Irreversible Inhibitors Cyclooxygenase Market by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 28 Asia Pacific Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 29 Asia Pacific Drug store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Drug store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 31 Asia Pacific Drug store & Retail Pharmacies Market by Country, 2019 - 2022, Million Units
TABLE 32 Asia Pacific Drug store & Retail Pharmacies Market by Country, 2023 - 2030, Million Units
TABLE 33 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 34 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 35 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, Million Units
TABLE 36 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, Million Units
TABLE 37 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 38 Asia Pacific Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 39 Asia Pacific Online Providers Market by Country, 2019 - 2022, Million Units
TABLE 40 Asia Pacific Online Providers Market by Country, 2023 - 2030, Million Units
TABLE 41 Asia Pacific Antiplatelet Market by Country, 2019 - 2022, USD Million
TABLE 42 Asia Pacific Antiplatelet Market by Country, 2023 - 2030, USD Million
TABLE 43 Asia Pacific Antiplatelet Market by Country, 2019 - 2022, Million Units
TABLE 44 Asia Pacific Antiplatelet Market by Country, 2023 - 2030, Million Units
TABLE 45 China Antiplatelet Market, 2019 - 2022, USD Million
TABLE 46 China Antiplatelet Market, 2023 - 2030, USD Million
TABLE 47 China Antiplatelet Market, 2019 - 2022, Million Units
TABLE 48 China Antiplatelet Market, 2023 - 2030, Million Units
TABLE 49 China Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 50 China Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 51 China Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 52 China Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 53 China Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 54 China Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 55 China Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 56 China Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 57 China Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 58 China Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 59 Japan Antiplatelet Market, 2019 - 2022, USD Million
TABLE 60 Japan Antiplatelet Market, 2023 - 2030, USD Million
TABLE 61 Japan Antiplatelet Market, 2019 - 2022, Million Units
TABLE 62 Japan Antiplatelet Market, 2023 - 2030, Million Units
TABLE 63 Japan Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 64 Japan Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 65 Japan Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 66 Japan Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 67 Japan Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 68 Japan Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 69 Japan Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 Japan Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 71 Japan Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 72 Japan Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 73 India Antiplatelet Market, 2019 - 2022, USD Million
TABLE 74 India Antiplatelet Market, 2023 - 2030, USD Million
TABLE 75 India Antiplatelet Market, 2019 - 2022, Million Units
TABLE 76 India Antiplatelet Market, 2023 - 2030, Million Units
TABLE 77 India Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 78 India Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 79 India Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 80 India Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 81 India Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 82 India Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 83 India Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 India Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 85 India Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 86 India Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 87 South Korea Antiplatelet Market, 2019 - 2022, USD Million
TABLE 88 South Korea Antiplatelet Market, 2023 - 2030, USD Million
TABLE 89 South Korea Antiplatelet Market, 2019 - 2022, Million Units
TABLE 90 South Korea Antiplatelet Market, 2023 - 2030, Million Units
TABLE 91 South Korea Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 92 South Korea Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 93 South Korea Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 94 South Korea Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 95 South Korea Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 96 South Korea Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 97 South Korea Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 98 South Korea Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 99 South Korea Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 100 South Korea Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 101 Singapore Antiplatelet Market, 2019 - 2022, USD Million
TABLE 102 Singapore Antiplatelet Market, 2023 - 2030, USD Million
TABLE 103 Singapore Antiplatelet Market, 2019 - 2022, Million Units
TABLE 104 Singapore Antiplatelet Market, 2023 - 2030, Million Units
TABLE 105 Singapore Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 106 Singapore Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 107 Singapore Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 108 Singapore Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 109 Singapore Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 110 Singapore Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 111 Singapore Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 112 Singapore Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 113 Singapore Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 114 Singapore Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 115 Malaysia Antiplatelet Market, 2019 - 2022, USD Million
TABLE 116 Malaysia Antiplatelet Market, 2023 - 2030, USD Million
TABLE 117 Malaysia Antiplatelet Market, 2019 - 2022, Million Units
TABLE 118 Malaysia Antiplatelet Market, 2023 - 2030, Million Units
TABLE 119 Malaysia Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 120 Malaysia Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 121 Malaysia Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 122 Malaysia Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 123 Malaysia Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 124 Malaysia Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 125 Malaysia Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 126 Malaysia Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 127 Malaysia Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 128 Malaysia Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 129 Rest of Asia Pacific Antiplatelet Market, 2019 - 2022, USD Million
TABLE 130 Rest of Asia Pacific Antiplatelet Market, 2023 - 2030, USD Million
TABLE 131 Rest of Asia Pacific Antiplatelet Market, 2019 - 2022, Million Units
TABLE 132 Rest of Asia Pacific Antiplatelet Market, 2023 - 2030, Million Units
TABLE 133 Rest of Asia Pacific Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 134 Rest of Asia Pacific Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 135 Rest of Asia Pacific Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 136 Rest of Asia Pacific Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 137 Rest of Asia Pacific Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 138 Rest of Asia Pacific Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 139 Rest of Asia Pacific Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 140 Rest of Asia Pacific Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 141 Rest of Asia Pacific Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 142 Rest of Asia Pacific Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 143 Key Information - Cipla Limited
TABLE 144 Key Information - Glenmark Pharmaceuticals Limited
TABLE 145 Key Information - Bayer AG
TABLE 146 KEY INFORMATION - AstraZeneca PLC
TABLE 147 Key Information - Daiichi Sankyo Company, Limited
TABLE 148 Key Information - Eli Lilly And Company
TABLE 149 key information - Otsuka Pharmaceutical Co., Ltd.
TABLE 150 Key Information - Sanofi S.A.
TABLE 151 Key Information - Lupin Limited
TABLE 152 Key Information - Chiesi Farmaceutici S.p.A

Asia Pacific Antiplatelet Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, and Injectable), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030